Current position:Home >Product >
2-[(4,4-dimethyl-2-oxidanyl-6-oxidanylidene-cyclohexen-1-yl)-(9-ethylcarbazol-3-yl)methyl]-5,5-dimethyl-cyclohexane-1,3-dione
2-[(4,4-dimethyl-2-oxidanyl-6-oxidanylidene-cyclohexen-1-yl)-(9-ethylcarbazol-3-yl)methyl]-5,5-dimethyl-cyclohexane-1,3-dione
|
|
Canonical SMILES:
CCN1C2=C(C=C(C=C2)C(C3C(=O)CC(CC3=O)(C)C)C4=C(CC(CC4=O)(C)C)O)C5=CC=CC=C51
Isomeric SMILES
CCN1C2=C(C=C(C=C2)C(C3C(=O)CC(CC3=O)(C)C)C4=C(CC(CC4=O)(C)C)O)C5=CC=CC=C51
InChI
InChI=1S/C31H35NO4/c1-6-32-21-10-8-7-9-19(21)20-13-18(11-12-22(20)32)27(28-23(33)14-30(2,3)15-24(28)34)29-25(35)16-31(4,5)17-26(29)36/h7-13,27-28,35H,6,14-17H2,1-5H3
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- (6E)-4-methoxy-6-[7-methoxy-5-(4-methoxyphenyl)-1,3,5,10b-tetrahydropyrazolo[1,5-c][1,3]benzoxazin-2-ylidene]cyclohexa-2,4-dien-1-one
- (6E)-6-[5-(3,4-dimethoxyphenyl)-7-methoxy-1,3,5,10b-tetrahydropyrazolo[1,5-c][1,3]benzoxazin-2-ylidene]-4-methoxy-cyclohexa-2,4-dien-1-one
- 2-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]-N-(4-sulfamoylphenyl)butanamide
- (6E)-4-methoxy-6-[7-methoxy-5-(3-methoxyphenyl)-1,3,5,10b-tetrahydropyrazolo[1,5-c][1,3]benzoxazin-2-ylidene]cyclohexa-2,4-dien-1-one
- 3-[2-(2,4-dimethoxyphenyl)-2-oxidanylidene-ethyl]benzo[g]chromen-2-one
- 1-(phenylmethyl)-4-(2-phenylsulfanylethyl)piperazine
- (6E)-6-[5-(2,3-dimethoxyphenyl)-7-methoxy-1,3,5,10b-tetrahydropyrazolo[1,5-c][1,3]benzoxazin-2-ylidene]-4-methoxy-cyclohexa-2,4-dien-1-one
- N-(5-nitropyridin-2-yl)-2-pyrimidin-2-ylsulfanyl-ethanamide
- (6E)-6-[5-(2,4-dimethoxyphenyl)-7-methoxy-1,3,5,10b-tetrahydropyrazolo[1,5-c][1,3]benzoxazin-2-ylidene]-4-methoxy-cyclohexa-2,4-dien-1-one
- (6E)-6-[3-(2-chlorophenyl)-2H-1,2-oxazol-5-ylidene]-4-methyl-cyclohexa-2,4-dien-1-one

